Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol effects on vasodilation in hypertension
NCT00648895Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Nov 2007
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nebivolol in hypertension (HTN), sponsored by Forest Laboratories. Started Nov 2007; status: completed.
02
Drugs
nebivolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00648895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00648895.